S.R. Drugs And Intermediates (Unit 3) Private Limited - Company Profile

It is a chemicals and materials private limited company based in Medak, Telangana, India, established in 2020.
2020 Medak, Telangana, India Active
Last Updated:
Access Report
About S.R. Drugs And Intermediates (Unit 3) Private Limited

S.R. Drugs And Intermediates (Unit 3) Private Limited, a active private limited company, was established on 03 June 2020 in Medak, Telangana, India. Engaging in industrial chemicals within the manufacturing sector, it holds CIN: U24230TG2020PTC140573. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.

Its leadership includes Satyanarayana Reddy Khairtabad (Director), Satyanarayana Reddy Chinnamail (Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at H.No 3-58, S.R.Chambers, Main Road, Ramachandrapuram,, Medak, Telangana, 502032.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24230TG2020PTC140573

  • Registration Number

    140573

  • Incorporation Date

    03 June 2020

  • Authorized Capital

    ₹1.00 M

  • Paid-Up Capital

    ₹0.10 M

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.00 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 5 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** %
  • Ebitda ****
  • Net Worth ****
  • Total Assets -3.85%
Company report

S.R. Drugs And Intermediates (Unit 3) Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into S.R. Drugs And Intermediates (Unit 3) Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at S.R. Drugs And Intermediates (Unit 3) Private Limited?
Current Directors
Name Designation Appointment Date Status
Satyanarayana Reddy Khairtabad Director 03 Jun 2020 Current
Satyanarayana Reddy Chinnamail Director 03 Jun 2020 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of S.R. Drugs And Intermediates (Unit 3).

S.R. Drugs And Intermediates (Unit 3) Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

S.R. Drugs And Intermediates (Unit 3) revenue growth over time
S.R. Drugs And Intermediates (Unit 3) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -3.85%
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of S.R. Drugs And Intermediates (Unit 3)?

Unlock access to S.R. Drugs And Intermediates (Unit 3)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at S.R. Drugs And Intermediates (Unit 3)?

S.R. Drugs And Intermediates (Unit 3) has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of S.R. Drugs And Intermediates (Unit 3), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped S.R. Drugs And Intermediates (Unit 3)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on S.R. Drugs And Intermediates (Unit 3)
Recent Activity within the Organization
  • Annual General Meeting

    The activity S.R. Drugs And Intermediates (Unit 3) Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    The activity S.R. Drugs And Intermediates (Unit 3) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was completed.

  • Director Appointment

    Progress on Satyanarayana Reddy Khairtabad was appointed as a Director was appointed as a Director on 03 Jun 2020 & has been associated with this company since 5 years 8 months . was documented.

  • Director Appointment

    Satyanarayana Reddy Chinnamail was appointed as a Director was appointed as a Director on 03 Jun 2020 & has been associated with this company since 5 years 8 months . was recorded as a recent event.

  • Company Incorporation

    S.R. Drugs And Intermediates (Unit 3) Private Limited was registered on 03 Jun 2020 with Roc Hyderabad & aged 5 years 8 months as per MCA records. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of S.R. Drugs And Intermediates (Unit 3) Private Limited?

The CIN of S.R. Drugs And Intermediates (Unit 3) Private Limited is U24230TG2020PTC140573.

Where is S.R. Drugs And Intermediates (Unit 3) Private Limited headquartered?

S.R. Drugs And Intermediates (Unit 3) Private Limited is headquartered at H.No 3-58, S.R.Chambers, Main Road, Ramachandrapuram,, Medak, Telangana, 502032.

When was S.R. Drugs And Intermediates (Unit 3) Private Limited incorporated?

S.R. Drugs And Intermediates (Unit 3) Private Limited was incorporated on 03 June 2020.

Who are the current directors of S.R. Drugs And Intermediates (Unit 3) Private Limited?

The current directors of S.R. Drugs And Intermediates (Unit 3) Private Limited are

What is the primary industry of S.R. Drugs And Intermediates (Unit 3) Private Limited?

The primary industry of S.R. Drugs And Intermediates (Unit 3) Private Limited is Manufacturing.

Is S.R. Drugs And Intermediates (Unit 3) Private Limited a listed company?

S.R. Drugs And Intermediates (Unit 3) Private Limited is unlisted.

What is the capital structure of S.R. Drugs And Intermediates (Unit 3) Private Limited?

The authorized capital of S.R. Drugs And Intermediates (Unit 3) Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available